Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 194

1.

Extrinsic factors influencing responses to psychotherapeutic drugs.

Overall JE, Hollister LE, Kimbell I Jr, Shelton J.

Arch Gen Psychiatry. 1969 Jul;21(1):89-94. No abstract available.

PMID:
5815781
2.

The computer analyzes two psychotherapeutic agents in anxiety-depressed states.

Falk MA.

Curr Ther Res Clin Exp. 1973 Jul;15(7):488-99. No abstract available.

PMID:
4198312
3.

A review of clinical studies with combinations of fluphenazine and nortriptyline.

Pigott PV.

Curr Med Res Opin. 1972;1(1):26-36. No abstract available.

PMID:
4589400
4.

A controlled outpatient trial of perphenazine--amitriptyline and chlorpromazine.

Haskell DS, McNair DM, Fisher S, Kahn RJ.

J Clin Pharmacol. 1974 Oct;14(10):536-42. No abstract available.

PMID:
4610016
5.

Specific indications for different classes of phenothiazines.

Hollister LE, Overall JE, Kimbell I Jr, Pokorny A.

Arch Gen Psychiatry. 1974 Jan;30(1):94-9. No abstract available.

PMID:
4148660
6.

Amitriptyline-perphenazine interaction in ambulatory schizophrenic patients. A controled study of drug interaction.

Chouinard G, Annable L, Serrano M, Albert JM, Charette R.

Arch Gen Psychiatry. 1975 Oct;32(10):1295-307.

PMID:
1101843
7.

[Pharmacologic combinations in the therapy of depression: experiences with Mutabon (perphenazine and amitriptyline)].

Invernizzi G, Sostero M, Vitali A, Campanella F.

Riv Sper Freniatr Med Leg Alien Ment. 1971 Dec 31;95(6):1143-81. Italian. No abstract available.

PMID:
5143725
8.

Prediction of response to phenothiazines in schizophrenia. A crossvalidation study.

Goldberg SC, Frosch WA, Drossman AK, Schooler NR, Johnson GF.

Arch Gen Psychiatry. 1972 Apr;26(4):367-73. No abstract available.

PMID:
4552130
9.

[Pharmacotherapy of mental disorders with a combination of amitriptyline and perphenazine].

Molcan J, Belanská M, Motýlová A, Wolf M, Polák L.

Act Nerv Super (Praha). 1968 Oct 3;10(3):318. German. No abstract available.

PMID:
5702544
10.

Patterns of symptom change in anxious depressed outpatients treated with different drugs.

Woodward JA, Henry BW, Overall JE.

Dis Nerv Syst. 1975 Mar;36(3):125-9.

PMID:
1112168
11.
12.

[Current problems of endogenous depression].

Núnek K.

Act Nerv Super (Praha). 1970 Jan 12;12(1):93-5. Czech. No abstract available.

PMID:
5418678
13.
14.

factors influencing response to major tranquilizer medications.

Kimbell I Jr, Overall JE, Faibish GM, Pokorny AD.

Dis Nerv Syst. 1972 Apr;33(4):223-30. No abstract available.

PMID:
5029910
15.

A controlled trial of combined medications on behavioral and extrapyramidal effects.

Simpson GM, Krakov L, Kunz-Bartholini E.

Acta Psychiatr Scand Suppl. 1970;212:20-7. No abstract available.

PMID:
4917968
16.

The effect of a protriptyline-perphenazine combination in chronic psychiatric patients.

St-Jean A, Ban TA, Scott J.

Curr Ther Res Clin Exp. 1966 Oct;8(10):483-6. No abstract available.

PMID:
4961168
17.

Clinical evaluation of doxepin in anxious depressed outpatients.

Goldstein BJ, Pinosky DG.

Curr Ther Res Clin Exp. 1969 Apr;11(4):169-77. No abstract available.

PMID:
4976335
18.

A double-blind randomized comparison of nortriptyline plus perphenazine versus nortriptyline plus placebo in the treatment of psychotic depression in late life.

Mulsant BH, Sweet RA, Rosen J, Pollock BG, Zubenko GS, Flynn T, Begley AE, Mazumdar S, Reynolds CF 3rd.

J Clin Psychiatry. 2001 Aug;62(8):597-604.

PMID:
11561930
19.

Prediction in anti-depressant therapy.

Martin IC, Leahy MR.

Br J Psychiatry. 1968 Oct;114(515):1289-91. No abstract available.

PMID:
4880980
20.

Verbal behaviour changes with depression treatment.

Marjerrison G, Deza PC, Silzer JC.

Can Psychiatr Assoc J. 1969 Oct;14(5):503-8. No abstract available.

PMID:
4899999
Items per page

Supplemental Content

Write to the Help Desk